Onduo will leverage Telcare’s ability to deliver near real-time blood glucose results to create effective care management programs targeted primarily to the Type 2 diabetes community. The Onduo platform integrates service, hardware and software to provide access to personalized and convenient diabetes care. Onduo’s team of clinicians and experts combine proven medical practices with breakthrough technologies to help take the guess work out of diabetes.
About BioTelemetry and Telcare
Diabetes is a chronic disease characterized by elevated blood sugar due to inefficient or deficient insulin production. In 2014, it was estimated that 422 million people globally suffer from the disease. Diabetes can be classified in two major subsets, type 1 and type 2. Type 1 diabetes is an autoimmune disease that occurs when the pancreas stops making insulin and therefore must be regulated via daily administration of insulin. Type 2 diabetes is a metabolic disorder in which a person’s body produces insulin, but is not able to regulate it efficiently. Over time, the disease can result in serious or life threatening complications, including damage to the heart, eyes, kidneys and nerves. It has been estimated that the global economic burden of diabetes is U.S.
 Roglic, G. (2016). Global report on diabetes. Retrieved
 National Diabetes Statistics Report, 2014. (2014). Retrieved
 NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4*4 million participants. Lancet 2016; published online
|FOR IMMEDIATE RELEASE|
|Heather C. Getz|